abstract |
The present invention provides fully human antibodies that specifically bind with high affinity to human FLT3 in extracellular domain 4 or 5. The present invention further provides a method of treating leukemia by administering an effective amount of the antibody alone or in combination with a therapeutic agent comprising an anticancer agent or methotrexate. |